COUPANG, INC. (CPNG): what the price requires
At today's price, COUPANG, INC. (CPNG) is priced for today's economics sustained for ~19.7 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/CPNG
Headline
| Field | Value |
|---|---|
| Ticker | CPNG |
| Company | COUPANG, INC. |
| Current price | $17.84/sh |
| Composition | Net retail sales 76% / Net other revenue 24% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin today | 0.7% |
| Must persist for | 19.7y |
| Multiple paid | 142x operating income |
Solve inputs: computed at a 10% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.7 years.
How unusual the bet is: elevated (limited comparison data)
| Reference | Value |
|---|---|
| sustained it ~10 years at this level | 14% |
| implied end-window share | 4% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 8.74x | 2 | expensive |
| Earnings | 7.96x | 1 | expensive |
| Relative | 4.40x | 2 | expensive |
| Growth | — | 0 | — |
Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.0%); the inversion above states its own rate.
Per-Model Detail (n=5)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $6.15 | 2.90x | no | FCF base $0.3B, growth 13% (input: historical growth), terminal g 4.0%, WACC 8.0%, 6yr projection |
| DCF Exit Multiple | Growth | $19.05 | 0.94x | no | Exit EV/EBITDA: 141.8x / 143.8x / 145.8x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $28.87 | 0.62x | yes | P/S fallback (negative EPS): Sector P/S 1.5x × TTM revenue — excluded from consensus |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $2.15 | 8.30x | yes | Reference only (book value floor): BV/sh $2.15, ROE negative |
| Two-Stage Excess Return | Asset | $1.94 | 9.19x | yes | Reference only (book value with convergence): BV/sh $2.15, ROE converges to ke |
| Discounted Future Market Cap | Growth | $16.90 | 1.06x | no | Rev $35.1B, growth 13% (input: historical growth; tapered), Terminal P/S: 0.8x / 0.9x / 1.1x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $0.00 | — | no | Negative/zero EPS — earnings-based value floored at $0 |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | $2.18 | 8.18x | yes | EBITDA $0.22B × sector EV/EBITDA 14.0x |
| FCF Yield | Earnings | $2.24 | 7.96x | yes | FCF $295.0M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | — |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | $28.87 | 0.62x | no | Revenue $35.13B × sector P/S 1.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | — | — | no | — |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $4.0b |
| Net debt / NOPAT (after-tax) | -22.77x (net cash) |
| Net debt / operating income (pre-tax) | -17.99x (net cash) |
| Interest coverage | 2.7x |
| Share count CAGR (dilution) | 1.0% |
| Burning cash | no |
Bullet Takeaways
- Coupang is the dominant e-commerce and logistics platform in South Korea, with a fast-growing Developing Offerings arm (Taiwan Rocket Delivery, Farfetch luxury, Coupang Eats, Coupang Play). Q1 2026 revenue grew 8%, and Developing Offerings revenue jumped 33% to $1.19B.
- The earnings trajectory is the tension. The core Product Commerce business is profitable and recovering, but consolidated margins are razor-thin (operating margin near 0.2%) and compressing as the company invests in Taiwan and absorbs the aftermath of a data incident. Management guided adjusted-EBITDA margin to contract 300 to 400 basis points year over year in Q2.
- At $18.02 the price embeds an extreme bet: about 143x operating income, implying growth held at the self-funding ceiling for roughly 20 years. Only about 14% of comparable fast-growers have sustained that pace. The bet is that today's thin margins are a deliberate investment phase, not a ceiling.
Bull Case
Read the earnings trajectory the way the company asks you to: the thin reported margin is a choice, and the underlying direction is up. Coupang grew consolidated revenue 8% in Q1 2026 and is guiding 9% to 10% constant-currency growth in Q2, while the core Product Commerce segment is profitable and recovering from a prior data incident. The standout is the Developing Offerings arm, where revenue grew 33% to $1.19 billion, spanning Taiwan Rocket Delivery, the acquired Farfetch luxury platform, Coupang Eats, and Coupang Play. The mature Korean business funds the new bets, and the new bets are growing four times faster than the consolidated average.
The moat in Korea is the asset the methods cannot easily price. Coupang built its own end-to-end logistics network, the Rocket Delivery infrastructure that puts most of the Korean population within reach of next-day or same-day delivery, and that physical network is extremely hard to replicate. The 10-K notes that the rise in Product Commerce net revenues is "primarily due to the growth in total net revenues per Product Commerce Active Customer ranging from 3% to 7% each quarter" (accession 0001834584-26-000024), the sign of a deepening, more valuable customer base rather than just more customers. That same logistics playbook is now being exported to Taiwan, where the company has built last-mile coverage of about 70% of the geography and roughly 75% of next-day volume.
The balance sheet supports the investment phase. Coupang holds net cash near $4 billion, so it can self-fund the Taiwan build-out and the Farfetch turnaround without raising capital. The bull case is the classic scaling-platform argument: the company is deliberately suppressing margins to capture two large new markets, and as Taiwan matures the way Korea did, the consolidated margin should expand toward the Product Commerce segment's profitability. At $18.02 the price is paying for that operating leverage to arrive; if Coupang replicates even a fraction of its Korean economics in Taiwan, the thin trailing margin is the wrong number to anchor on.
Bear Case
The capital-allocation question is the heart of the bear case, because Coupang is spending aggressively on bets that may not earn their cost. The Taiwan expansion and the Farfetch acquisition are large, open-ended investments: Taiwan requires building a duplicate of the Korean logistics network from scratch in a market with entrenched competitors, and Farfetch was a distressed luxury platform Coupang bought in January 2024 that has yet to prove it fits the portfolio. Management guided consolidated adjusted-EBITDA margin to contract 300 to 400 basis points year over year, which is the company telling investors that the spending is accelerating, not winding down. When a company at a razor-thin 0.2% operating margin keeps raising its investment, the risk is that the new markets never reach the profitability of the home market.
The valuation makes the stakes extreme. At $18.02 (June 27, 2026) the price embeds about 143x company-wide operating income, which implies growth held at the self-funding ceiling for roughly 20 years. Only about 14% of comparable fast-growers have sustained that pace for even 10 years. No standard valuation family reaches the price: the relative price-to-sales fallback lands near $29, but it is excluded from consensus because earnings are negative, and the asset and FCF-based references land near $2. The blended X-ray near $2 sits a fraction of the price, because there is almost no current operating profit to capitalize. The price is entirely a bet on a future margin that does not yet exist.
The operating risks compound the valuation risk. Coupang carries distress signals in the data, including sustained net losses, negative retained earnings, and an Altman distress reading, which is why the projection-based methods are gated off as unreliable. The data incident that pressured the recent quarters is a reminder that a logistics-and-data platform carries operational and cybersecurity risk that can dent both margins and trust. Currency is a constant headwind, since most revenue is won in non-dollar markets. The bet against Coupang is that the Taiwan and Farfetch investments dilute returns for years, that the home market alone cannot justify 143x operating income, and that the thin margin is closer to the business's reality than to a temporary investment phase.
Valuation
At $18.02, inverting the price puts Coupang at roughly 143x company-wide operating income, which solves to growth held at the 25% self-funding ceiling for about 20 years, computed at a 10% cost of capital. Each percentage point of cost of capital moves the implied horizon by roughly 2.7 years. That is among the most demanding assumptions in the universe, and it reflects how little current operating profit there is to anchor on rather than an extreme growth forecast: at a 0.2% operating margin, almost any positive price produces a very high multiple.
The model families largely cannot value the company on current numbers. The projection-based methods, DCF, exit-multiple, discounted-future-market-cap, and Peter Lynch, are all gated off because of distress signals: sustained net losses, negative retained earnings, and an Altman distress reading. What remains is reference-only: the relative price-to-sales fallback near $29 (excluded from consensus for negative EPS), the book-value floor near $2, and the FCF-yield reference near $2. The blended X-ray near $2 is a fraction of the price.
The honest valuation conclusion is that standard frames cannot justify $18.02; the price is a probability-weighted bet on operating leverage that has not yet materialized. The case for the price is that today's thin margin is a deliberate investment in Taiwan and Farfetch, and that consolidated profitability will expand toward the Korean core's economics as those markets mature. The case against it is that the methods anchored to current results say the business is worth a small fraction of the price. The deciding variable is whether the new-market investments convert into the kind of margins Coupang already earns in Korea, and on what timeline.
Catalysts
Margin trajectory is the catalyst that decides the thesis. Management guided consolidated adjusted-EBITDA margin to contract 300 to 400 basis points year over year in Q2 2026 as Taiwan and other investments ramp. The market needs to see when that contraction inflects back toward expansion, so the quarterly adjusted-EBITDA margin and the Product Commerce segment margin are the cleanest reads on whether the investment phase is paying off.
Taiwan is the growth catalyst to track. The company has built last-mile coverage of about 70% of the geography and roughly 75% of next-day volume, and Developing Offerings revenue grew 33% to $1.19 billion. Evidence that Taiwan is approaching the unit economics of the Korean network would validate the price; continued open-ended losses there would undercut it.
The recovery from the data incident is the near-term overhang. Coupang has been working through post-incident customer trust and cost effects, so a clean recovery in Product Commerce growth and customer engagement is the signal the core is healthy. Farfetch integration progress, currency moves in Korea and Taiwan, and the pace of first-party and marketplace assortment expansion are the other variables to monitor. The 2026 consensus still points to a small per-share loss on revenue near $37.7 billion.
Sources: Coupang Q1 2026 earnings transcript (AOL), Coupang Taiwan and Developing Offerings (Korea Herald), Coupang investor summary (Quartr)
Peer Cohorts (Per Segment, With Filing Citations)
Product Commerce (reported)
- MELI (MercadoLibre Inc)
- (no filing in the citation store)
- PDD (PDD Holdings Inc)
- (no filing in the citation store)
- JD (JD.com, Inc.)
- (no filing in the citation store)
- BABA (Alibaba Group Holding Limited)
- (no filing in the citation store)
- AMZN (AMAZON COM INC)
- (no filing in the citation store)
- EBAY (eBay Inc.)
- (no filing in the citation store)
- CHWY (CHEWY, INC.)
- (no filing in the citation store)
Developing Offerings (reported)
- GRAB (GRAB HOLDINGS LIMITED)
- (no filing in the citation store)
- DASH (DOORDASH, INC.)
- (no filing in the citation store)
- UBER (UBER TECHNOLOGIES, INC.)
- (no filing in the citation store)
- MELI (MercadoLibre Inc)
- (no filing in the citation store)
- ETSY (ETSY, INC)
- (no filing in the citation store)
- EBAY (eBay Inc.)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.